Derivation of an Outcome-Driven Threshold for Aortic Pulse Wave Velocity: An Individual-Participant Meta-Analysis
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu metaanalýza, časopisecké články, práce podpořená grantem
PubMed
37470187
PubMed Central
PMC10424824
DOI
10.1161/hypertensionaha.123.21318
Knihovny.cz E-zdroje
- Klíčová slova
- cardiovascular diseases, diabetes mellitus, hypertension, metabolic syndrome, pulse wave analysis,
- MeSH
- analýza pulzové vlny škodlivé účinky MeSH
- aorta MeSH
- arterie MeSH
- hypertenze * diagnóza epidemiologie komplikace MeSH
- kardiovaskulární nemoci * diagnóza epidemiologie etiologie MeSH
- lidé MeSH
- rizikové faktory MeSH
- tuhost cévní stěny * fyziologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- práce podpořená grantem MeSH
BACKGROUND: Aortic pulse wave velocity (PWV) predicts cardiovascular events (CVEs) and total mortality (TM), but previous studies proposing actionable PWV thresholds have limited generalizability. This individual-participant meta-analysis is aimed at defining, testing calibration, and validating an outcome-driven threshold for PWV, using 2 populations studies, respectively, for derivation IDCARS (International Database of Central Arterial Properties for Risk Stratification) and replication MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease Health Survey - Copenhagen). METHODS: A risk-carrying PWV threshold for CVE and TM was defined by multivariable Cox regression, using stepwise increasing PWV thresholds and by determining the threshold yielding a 5-year risk equivalent with systolic blood pressure of 140 mm Hg. The predictive performance of the PWV threshold was assessed by computing the integrated discrimination improvement and the net reclassification improvement. RESULTS: In well-calibrated models in IDCARS, the risk-carrying PWV thresholds converged at 9 m/s (10 m/s considering the anatomic pulse wave travel distance). With full adjustments applied, the threshold predicted CVE (hazard ratio [CI]: 1.68 [1.15-2.45]) and TM (1.61 [1.01-2.55]) in IDCARS and in MONICA (1.40 [1.09-1.79] and 1.55 [1.23-1.95]). In IDCARS and MONICA, the predictive accuracy of the threshold for both end points was ≈0.75. Integrated discrimination improvement was significant for TM in IDCARS and for both TM and CVE in MONICA, whereas net reclassification improvement was not for any outcome. CONCLUSIONS: PWV integrates multiple risk factors into a single variable and might replace a large panel of traditional risk factors. Exceeding the outcome-driven PWV threshold should motivate clinicians to stringent management of risk factors, in particular hypertension, which over a person's lifetime causes stiffening of the elastic arteries as waypoint to CVE and death.
Biomedical Science Group Faculty of Medicine University of Leuven Belgium
Centre for Environmental Sciences Hasselt University Belgium
Department of Cardiology Shanghai General Hospital China
Department of Cardiology the 1st Affiliated Hospital of Sun Yat Sen University Guangzhou China
Department of Chronic Disease Prevention Finnish Institute for Health and Welfare Turku Finland
Department of Medicine Turku University Hospital and University of Turku Finland
Department of Medicine University of Padova Italy
Faculty of Medicine Charles University Pilsen Czech Republic
Hypertension Unit Department of Hypertension and Diabetology Medical University of Gdańsk Poland
Non Profit Research Association Alliance for the Promotion of Preventive Medicine Belgium
School of Physiology University of the Witwatersrand Johannesburg South Africa
Servicio de Clínica Médica Sección Hipertensión Arterial Hospital Italiano de Buenos Aires Argentina
Zobrazit více v PubMed
Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74:1237–1263. doi: 10.1016/j.jacc.2019.07.012 PubMed PMC
Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, et al. ; Artery Society. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30:445–448. doi: 10.1097/HJH.0b013e32834fa8b0 PubMed
Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al. . 2007 ESH-ESC practice Guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens. 2007;25:1751–1762. doi: 10.1097/HJH.0b013e3282f0580f PubMed
Joint Committee for Guideline Revision. 2018 Chinese guidelines for prevention and treatment of hypertension — a report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2022;16:182–241. doi: 10.11909/j.issn.1671-5411.2019.03.014 PubMed PMC
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. ; ESC Scientific Document Group. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–3104. doi: 10.1093/eurheartj/ehy339 PubMed
Huybrechts SAM, Devos DG, Vermeersch SJ, Mahieu D, Achten E, de Backer TLM, Segers P, Van Bortel LM. Carotid to femoral pulse wave velocity: a comparison of real travelled aortic path lengths determined by MRI and superficial measurements. J Hypertens. 2011;29:1577–1582. doi: 10.1097/HJH.0b013e3283487841 PubMed
The Reference Values for Arterial Stiffness’ collaboration. Determinants of pulse wave velocity in healthy people and the presence of cardiovascular risk factors: “establishing normal and reference values”. Eur Heart J. 2010;31:2338–2350. doi: 10.1093/eurheartj/ehq165 PubMed PMC
Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–1117. doi: 10.1161/01.hyp.33.5.1111 PubMed
London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38:434–438. doi: 10.1161/01.hyp.38.3.434 PubMed
Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM. Stiffness of capacitive and conduit arteries. Prognostic significance for end-stage renal disease patients. Hypertension. 2005;45:592–596. doi: 10.1161/01.HYP.0000159190.71253.c3 PubMed
Adragâo T, Pires A, Birne R, Dias Curto J, Lucas C, Gonçalves M, Pita Negrâo A. A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant. 2009;24:997–1002. doi: 10.1093/ndt/gfn584 PubMed
Avramovski P, Janakievska P, Sotiroski K, Zafirova-Ivanovska B, Sikole A. Aortic pulse wave velocity is a strong predictor of all-cause and cardiovascular mortality in chronic dialysis patients. Ren Fail. 2013;36:176–186. doi: 10.3109/0886022x.2013.843359 PubMed
Broyd CJ, Patel K, Pugliese F, Chebab O, Mathur A, Baumbach A, Ozkor M, Kennon S, Mullen M. Pulse wave velocity can be accurately measured during transcatheter aortic calve implantation and used for post-procedure risk stratification. J Hypertens. 2019;37:1845–1852. doi: 10.1097/HJH.0000000000002141 PubMed
Ryliškyte L, Navickas R, Šerpytis P, Puronaite R, Zupkauskiene J, Juceviciene A, Badariene J, Rimkiene MA, Ryliškiene K, Skiauteryte E, et al. . Association of aortic stiffness, carotid intima-media thickness and endothelial function with cardiovascular events in metabolic syndrome subjects. Blood Press. 2019;28:131–138. doi: 10.1080/08037051.2019.1569461 PubMed
Zhang Q, Yin K, Zhu M, Lin X, Fang Y, Lu J, Li Z, Ni Z. Combining pulse wave velocity with galectin-3 to predict mortality and cerebrovascular and cardiovascular events in hemodialysis patients. Front Med. 2020;7:579021. doi: 10.3389/fmed.2020.579021 PubMed PMC
Shokawa T, Imazu M, Yamamoto H, Toyofuku M, Tasaki N, Okimoto T, Yamane K, Kohno N. Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima study. Circ J. 2005;69:259–264. doi: 10.1253/circj.69.259 PubMed
Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S, et al. ; Health ABC Study. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005;111:3384–3390. doi: 10.1161/CIRCULATIONAHA.104.483628 PubMed
Inoue N, Maeda R, Kawakami H, Shokawa T, Yamamoto H, Ito C, Sasaki H. Aortic pulse wave velocity predicts cardiovascular mortality in middle-aged and elderly Japanse men. Circ J. 2009;73:549–553. doi: 10.1253/circj.cj-08-0492 PubMed
Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, Torp Pedersen C, Olsen MH. Thresholds for pulse wave velocity, urinary albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts. J Hypertens. 2012;30:1928–1936. doi: 10.1097/HJH.0b013e328356c579 PubMed
Takami T, Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res. 2003;26:609–614. doi: 10.1291/hypres.26.609 PubMed
Aparicio LS, Huang QF, Melgarejo JD, Wei DM, Thijs L, We FF, Gilis-Malinowska N, Sheng CS, Boggia J, Niiranen TJ, et al. . The International Database of Central Arterial Properties for Risk Stratification: research objectives and baseline characteristics of participants. Am J Hypertens. 2022;35:54–64. doi: 10.1093/ajh/hpab139 PubMed PMC
Hansen TW, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113:664–670. doi: 10.1161/CIRCULATIONAHA.105.579342 PubMed
World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Am Med Assoc. 2013;310:2191–2194. doi: 10.1001/jama.2013.281053 PubMed
Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension. 1995;26:485–490. doi: 10.1161/01.hyp.26.3.485 PubMed
Vermeersch SJ, Rietzschel ER, De Buyere ML, Van Bortel LM, Gillebert TC, Verdonck PR, Laurent S, Segers P, Boutouyrie P. Distance measurements for the assessment of carotid to femoral pulse wave velocity. J Hypertens. 2009;27:2377–2385. doi: 10.1097/HJH.0b013e3283313a8a PubMed
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabet Care. 2003;26(Suppl. 1):S5–S20. doi: 10.2337/diacare.26.2007.s5 PubMed
Hosmer DW, Jr, Leleshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989.
Gu YM, Thijs L, Li Y, Asayama K, Boggia J, Hansen TW, Liu YP, Ohkubo T, Bjorklund-Bodegard K, Jeppesen J, et al. ; International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators. Outcome-driven thresholds for ambulatory pulse pressure in 9938 participants recruited from 11 populations. Hypertension. 2014;63:229–237. doi: 10.1161/HYPERTENSIONAHA.113.02179 PubMed PMC
Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Ibsen H, et al. ; International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115:2145–2152. doi: 10.1161/CIRCULATIONAHA.106.662254 PubMed
Pencina MJ, D’Agostino RB, Sr, D’Agostino RB, Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72; discussion 207. doi: 10.1002/sim.2929 PubMed
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. doi: 10.1016/s0140-6736(02)11911-8 PubMed
Li Y, Thijs L, Zhang ZY, Asayama K, Hansen TW, Boggia J, Björklund-Bodegård K, Yang WY, Niiranen TJ, Ntineri A, et al. ; International Database on Ambulatory and Home Blood Pressure in Relation to Cardiovascular Outcome Investigators. Opposing age-related trends in absolute and relative risk of adverse health outcomes associated with out-of-office blood pressure. Hypertension. 2019;74:1333–1342. doi: 10.1161/HYPERTENSIONAHA.119.12958 PubMed PMC
Asia Pacific Cohort Studies Collaboration. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Intern J Epidemiol. 2003;N32:563–572. doi: 10.1093/ije/dyg106 PubMed
Laurent S, Chatellier G, Azizi M, Calvet D, Choukroun G, Danchin N, Delsart P, Girerd X, Gosse P, Khettab H, et al. ; SPARTE Investigators. SPARTE Study: normalization of arterial stiffness and cardiovascular events in patients with hypertension at medium to very high risk. Hypertension. 2021;78:983–995. doi: 10.1161/HYPERTENSIONAHA.121.17579 PubMed PMC
Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O’Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation. 1983;68:50–58. doi: 10.1161/01.cir.68.1.50 PubMed
Wagenseil J, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev. 2009;89:957–989. doi: 10.1152/physrev.00041.2008 PubMed PMC
Wagenseil J, Mecham RP. Elastin in large artery stiffness and hypertension. J Cardiovasc Trans Res. 2012;5:264–273. doi: 10.1007/s12265-012-9349-8 PubMed PMC
Upadhya B, Pajewski NM, Rocco MV, Hundley WG, Aurigemma G, Hamilton CA, Bates JT, He J, Chen J, Chonchol M, et al. ; SPRINT Research Group. Effect of intensive blood pressure control on aortic stiffness in the SPRINT-HEART. Hypertension. 2021;77:1571–1580. doi: 10.1161/HYPERTENSIONAHA.120.16676 PubMed PMC